Register for real-time alerts, custom portfolio, and market movers
Period:
Draw Mode:
| Volume | 19,743 |
|
|||||
| News | - | ||||||
| Day High | 1.73 | Low High |
|||||
| Day Low | 1.60 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Biofrontera Inc | BFRI | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| -0.04 | -2.37% | 1.65 | 14:39:35 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 1.66 | 1.60 | 1.73 | 1.69 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 151 | 19,743 | $ 1.68 | $ 33,134 | - | 0.61 - 13.42 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 14:39:35 | 98 | $ 1.65 | USD |
Biofrontera Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 2.55M | 1.52M | - | 34.07M | -20.13M | -13.26 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Biofrontera News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical BFRI Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 1.71 | 1.7861 | 1.376 | 1.57 | 60,389 | -0.06 | -3.51% |
| 1 Month | 1.57 | 2.4302 | 1.376 | 1.88 | 128,744 | 0.08 | 5.10% |
| 3 Months | 1.24 | 2.4302 | 0.61 | 1.12 | 843,644 | 0.41 | 33.06% |
| 6 Months | 4.17 | 5.28 | 0.61 | 1.23 | 416,662 | -2.52 | -60.43% |
| 1 Year | 11.438 | 13.42 | 0.61 | 3.19 | 271,772 | -9.79 | -85.57% |
| 3 Years | 81.80 | 292.60 | 0.61 | 121.52 | 2,243,492 | -80.15 | -97.98% |
| 5 Years | 81.80 | 292.60 | 0.61 | 121.52 | 2,243,492 | -80.15 | -97.98% |
Biofrontera Description
| Biofrontera Inc is a biopharmaceutical company specializing in the commercialization of pharmaceutical products for the treatment of dermatological conditions, diseases caused by exposure to sunlight that result in sun damage to the skin. Its licensed products focus on the treatment of actinic keratoses, which are skin lesions that can sometimes lead to skin cancer. It also markets a topical antibiotic for the treatment of impetigo, a bacterial skin infection. |
